We wrapped up at the Patients as Partners in Clinical Research conference in Boston couple weeks back. The biggest takeaway: patients aren’t just participants — they’re essential partners in shaping better clinical trials and future treatments….
Patients as Partners 2026 Key Highlights 1. AI Moving from Concept to Clinical RealityDiscussions showcased real-world AI applications—from patient digital twins to AI-assisted protocol development. The emphasis was on responsible implementation, governance, and measurable impact to…
As we return from an energizing week at SCOPE 2026 in Orlando, one thing is clear: the industry conversation has evolved. The focus has shifted from experimentation to execution — from “Should we modernize?” to “How…
Team TrialX at SCOPE 2026: Sharib Khan (Co-founder & CEO), Wes Martz (Senior Director of Client Services), Beth Dickson (VP, Business Development), and Brandon Ramos (Sales Development Representative) SCOPE 2026 once again brought together leaders across…
The 17th Annual SCOPE Summit once again brought together leaders across clinical operations, digital health, patient engagement, and data innovation to shape the future of clinical research. This year, the tone was clear: the industry is…
“As we close 2025, I’m incredibly proud of what the TrialX team has built over more than 17 years of innovation and delivery. From launching our first app in 2008 with pioneers like Google Health and…
2025 has seen 43 novel FDA drug approvals – new drugs never before approved or marketed in the U.S for a condition – introducing high-impact therapies that are redefining what “breakthrough” truly means. This year’s portfolio…